• Mashup Score: 0

    James Harding, MD, highlighted current and emerging areas of research in biliary tract cancer, including key contributions from TOPAZ-1 and the phase 3 SWOG 1815 trial, the development of immunotherapy and chemotherapy combinations, and continued efforts to utilize personalized medicine in clinical practice.

    Tweet Tweets with this article
    • James Harding, MD, of @MSKCancerCenter, highlights current and emerging areas of research in biliary tract cancer, including key contributions from TOPAZ-1 and the phase 3 SWOG 1815 trial. #stomachcancer https://t.co/8jo2wYvsxD https://t.co/Vh0uf0IOK3

  • Mashup Score: 0

    James Harding, MD, highlighted current and emerging areas of research in biliary tract cancer, including key contributions from TOPAZ-1 and the phase 3 SWOG 1815 trial, the development of immunotherapy and chemotherapy combinations, and continued efforts to utilize personalized medicine in clinical practice.

    Tweet Tweets with this article
    • James Harding, MD, of @MSKCancerCenter, highlights current and emerging areas of research in biliary tract cancer, including key contributions from TOPAZ-1 and the phase 3 SWOG 1815 trial. #stomachcancer https://t.co/1C2KAqk35t https://t.co/pjocST7DLu

  • Mashup Score: 3

    There is currently no established guidelines for nutrition for stomach cancer patients, impacting their quality of life.

    Tweet Tweets with this article
    • Thank you @TOYourHealth9 @CTVNews for highlighting our @CCSResearch @CIHR_IRSC collaboration with @mygutfeelingca to study ways to improve nutrition for #stomachcancer patients! https://t.co/CRtmKtX7xZ

  • Mashup Score: 0

    James Harding, MD, highlighted current and emerging areas of research in biliary tract cancer, including key contributions from TOPAZ-1 and the phase 3 SWOG 1815 trial, the development of immunotherapy and chemotherapy combinations, and continued efforts to utilize personalized medicine in clinical practice.

    Tweet Tweets with this article
    • James Harding, MD, of @MSKCancerCenter, highlights current and emerging areas of research in biliary tract cancer, including key contributions from TOPAZ-1 and the phase 3 SWOG 1815 trial. #stomachcancer https://t.co/azzKJgLf3X https://t.co/6iDP4kYFd0

  • Mashup Score: 5

    In late 2018, Estefania E. Marchan and her husband, Peter Richman, decided to start planning for a family. When Estefania’s obstetrician asked if the couple wanted to undergo cancer screening as part of the planning process, Estefania, who had a family history of stomach cancer, agreed. “It was pretty obvious to me that it was going to be something that was hereditary,” Estefania said.

    Tweet Tweets with this article
    • After discovering she was at high risk for #StomachCancer, Estefania Marchan underwent surgery to remove her stomach. Two years later, she gave birth to her daughter via IVF pregnancy. Read Estefania's story. https://t.co/Wt80PWyxFC #survivorship